Late graft failure of pig-to-rhesus renal xenografts has features of glomerulopathy and recipients have anti-swine leukocyte antigen class I and class II antibodies
- PMID: 38761019
- PMCID: PMC11104517
- DOI: 10.1111/xen.12862
Late graft failure of pig-to-rhesus renal xenografts has features of glomerulopathy and recipients have anti-swine leukocyte antigen class I and class II antibodies
Abstract
Prolonged survival in preclinical renal xenotransplantation demonstrates that early antibody mediated rejection (AMR) can be overcome. It is now critical to evaluate and understand the pathobiology of late graft failure and devise new means to improve post xenograft outcomes. In renal allotransplantation the most common cause of late renal graft failure is transplant glomerulopathy-largely due to anti-donor MHC antibodies, particularly anti-HLA DQ antibodies. We evaluated the pig renal xenograft pathology of four long-surviving (>300 days) rhesus monkeys. We also evaluated the terminal serum for the presence of anti-SLA class I and specifically anti-SLA DQ antibodies. All four recipients had transplant glomerulopathy and expressed anti-SLA DQ antibodies. In one recipient tested for anti-SLA I antibodies, the recipient had antibodies specifically reacting with two of three SLA I alleles tested. These results suggest that similar to allotransplantation, anti-MHC antibodies, particularly anti-SLA DQ, may be a barrier to improved long-term xenograft outcomes.
Keywords: SLA‐DQ; anti‐MHC antibodies; major histocompatibility complex; swine leukocyte antigen; transplant glomerulopathy; xenoantibodies.
© 2024 The Authors. Xenotransplantation published by John Wiley & Sons Ltd.
Conflict of interest statement
Similar articles
-
Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?Xenotransplantation. 2023 Jul-Aug;30(4):e12816. doi: 10.1111/xen.12816. Epub 2023 Aug 7. Xenotransplantation. 2023. PMID: 37548030 Free PMC article. Review.
-
Human leukocyte antigen mismatch and circulating donor-specific antibodies predict graft loss after kidney transplantation: A retrospective study from Campania region - Italy.Hum Immunol. 2024 Nov;85(6):111166. doi: 10.1016/j.humimm.2024.111166. Epub 2024 Nov 5. Hum Immunol. 2024. PMID: 39504688
-
HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies.Front Immunol. 2024 Nov 20;15:1493878. doi: 10.3389/fimmu.2024.1493878. eCollection 2024. Front Immunol. 2024. PMID: 39635538 Free PMC article.
-
Prevalence of anti-HLA antibodies among live related renal transplant recipients: A retrospective observational study from a tertiary healthcare Center in India.Transpl Immunol. 2024 Dec 21:102164. doi: 10.1016/j.trim.2024.102164. Online ahead of print. Transpl Immunol. 2024. PMID: 39716647
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.
Cited by
-
Allosensitisation in NHP results in cross-reactive anti-SLA antibodies not detected by a lymphocyte-based flow cytometry crossmatch.HLA. 2024 Jul;104(1):e15599. doi: 10.1111/tan.15599. HLA. 2024. PMID: 39041289
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials